tiprankstipranks
Pediatrix Medical sees FY24 adjusted EBITDA at high end of $205M-$215M range
The Fly

Pediatrix Medical sees FY24 adjusted EBITDA at high end of $205M-$215M range

The company previously announced 2024 outlook of expected adjusted EBITDA in a range of $205M-$215M. The company currently believes it will achieve the high end of the range and that 2024 adjusted EBITDA may exceed such range. The company will announce its fourth quarter and full year 2024 results on February 20.

Invest with Confidence:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App